TCL Archive In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR April 15, 1994
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Golomb, Weinstein Head ASCO, AACR; Abeloff, Moses Presidents Elect; Sackett Heads AUR June 1, 1990
TCL Archive NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy. October 1, 1999
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
